N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) measurement is well‐established for diagnosis and risk stratification in suspected or established HF,3 and current guidelines recommend specialist cardiology referral for patients with elevated levels.4 The gene discussed is NPPB; the disease is hydrops fetalis.